This week we sat down with John Faragon to talk about the use of casirivimab and imdevimab as post-exposure prevention of COVID-19. Learn about who would benefit from this drug combination, when to administer it, and everything healthcare providers need to know.

Help us track the number of listeners our episode gets by filling out this brief form!